New drug launches into Australia threatened by "politicised" reimbursement decisions
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies are giving the Australian government a warning about the future of the industry as a result of a recent policy change that means drug reimbursement decisions for the country's state-funded pharmaceutical benefits scheme (PBS) are being deferred by Cabinet.